[go: up one dir, main page]

DE69630184D1 - Verfahren zur Herstellung von 1-substituierten Pyrrol-3-carbonsäure-Derivaten - Google Patents

Verfahren zur Herstellung von 1-substituierten Pyrrol-3-carbonsäure-Derivaten

Info

Publication number
DE69630184D1
DE69630184D1 DE69630184T DE69630184T DE69630184D1 DE 69630184 D1 DE69630184 D1 DE 69630184D1 DE 69630184 T DE69630184 T DE 69630184T DE 69630184 T DE69630184 T DE 69630184T DE 69630184 D1 DE69630184 D1 DE 69630184D1
Authority
DE
Germany
Prior art keywords
carboxylic acid
substituted pyrrole
preparation
acid derivatives
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69630184T
Other languages
English (en)
Other versions
DE69630184T2 (de
Inventor
Masahiro Imoto
Akira Mizuno
Makoto Shibata
Tomoe Iwamori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asubio Pharma Co Ltd
Original Assignee
Daiichi Suntory Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Suntory Pharma Co Ltd filed Critical Daiichi Suntory Pharma Co Ltd
Application granted granted Critical
Publication of DE69630184D1 publication Critical patent/DE69630184D1/de
Publication of DE69630184T2 publication Critical patent/DE69630184T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE69630184T 1995-11-02 1996-10-31 Verfahren zur Herstellung von 1-substituierten Pyrrol-3-carbonsäure-Derivaten Expired - Fee Related DE69630184T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP30854095 1995-11-02
JP30854095 1995-11-02
US08/741,911 US5684161A (en) 1995-11-02 1996-10-31 Process for preparing 1-substituted pyrrole-3-carboxylic acid derivatives

Publications (2)

Publication Number Publication Date
DE69630184D1 true DE69630184D1 (de) 2003-11-06
DE69630184T2 DE69630184T2 (de) 2004-08-12

Family

ID=26565581

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69630184T Expired - Fee Related DE69630184T2 (de) 1995-11-02 1996-10-31 Verfahren zur Herstellung von 1-substituierten Pyrrol-3-carbonsäure-Derivaten

Country Status (8)

Country Link
US (1) US5684161A (de)
EP (1) EP0771790B1 (de)
JP (1) JPH09183765A (de)
AT (1) ATE251135T1 (de)
AU (1) AU704349B2 (de)
CA (1) CA2189297C (de)
DE (1) DE69630184T2 (de)
ES (1) ES2206536T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020845A1 (fr) 1995-12-01 1997-06-12 Suntory Limited Derives de pyrroloazepine
JPH10251258A (ja) 1997-03-14 1998-09-22 Suntory Ltd ピロロアゼピン系化合物
JPH11193289A (ja) 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド誘導体
JPH11193290A (ja) 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド系化合物
DK2215071T3 (en) 2007-11-30 2015-10-05 Zynerba Pharmaceuticals Inc Prodrugs of tetrahydocannabinol, compositions containing prodrugs of tetrahydrocannabinol, as well as methods of use thereof
CN106831528B (zh) * 2017-02-16 2020-02-18 河南师范大学 一种吡咯-3-甲酸酯类化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4560700A (en) * 1985-02-08 1985-12-24 Merrell Dow Pharmaceuticals Inc. Pyrrole-3-carboxylate cardiotonic agents
JPH06104658B2 (ja) 1988-06-23 1994-12-21 三菱化成株式会社 ピロールカルボン酸誘導体

Also Published As

Publication number Publication date
DE69630184T2 (de) 2004-08-12
US5684161A (en) 1997-11-04
CA2189297C (en) 2004-09-21
ATE251135T1 (de) 2003-10-15
AU704349B2 (en) 1999-04-22
JPH09183765A (ja) 1997-07-15
EP0771790B1 (de) 2003-10-01
AU7055596A (en) 1997-05-08
CA2189297A1 (en) 1997-05-03
ES2206536T3 (es) 2004-05-16
EP0771790A1 (de) 1997-05-07

Similar Documents

Publication Publication Date Title
ATE282020T1 (de) Verfahren zur herstellung von 2-aminomalonsäure- derivaten
DE69802231D1 (de) Verfahren zur Herstellung von Aminobenzol-Derivaten
ATE35417T1 (de) Verfahren zur herstellung von phosphorhaltigen cyanhydrinderivaten.
ATE194341T1 (de) Verfahren zur herstellng von cyano- methoxyiminomethylderivaten
DE69630184D1 (de) Verfahren zur Herstellung von 1-substituierten Pyrrol-3-carbonsäure-Derivaten
ATE107295T1 (de) Verfahren zur herstellung von 1,5-benzothiazepin- derivaten.
DE69516156D1 (de) Verfahren zur herstellung von alkoxyimino acetamid-derivaten
DE69937988D1 (de) Verfahren zur herstellung von 3-cephemderivaten
DE69705802D1 (de) Verfahren zur Herstellung von 4-Amino-1,2,4-Triazolen
DE69809888D1 (de) Verfahren zur Herstellung von alpha-Aminoketonen
ATE225329T1 (de) Verfahren zur herstellung von r-(-)-carnitin
AU563050B2 (en) Synthesis of azetidin-3-ols
DE69733716D1 (de) Verfahren zur herstellung von imidazolderivaten
ATE194840T1 (de) Verfahren zur herstellung von antifolaten 4- hydroxypyrrolo 2,3-d pyrimidinderivaten
DE69130995D1 (de) Verfahren zur Herstellung von 5-Arylhydantoin
DE69921795D1 (de) Verfahren zur herstellung von benzothiophencarbonsäureamid-derivaten
ATE236132T1 (de) Verfahren zur herstellung von 1,3-diaza- spiro(4.4)non-1-en-4-on derivaten und 1-cyano-1- acylaminocyclopentan zwischenprodukte
ATE25680T1 (de) Verfahren zur herstellung von 4-amino-5-dialkoxy- methylpyrimidinderivaten.
KR970027055A (ko) 1-치환 피롤-3-카르복시산 유도체의 제조방법
DE60000375D1 (de) Verfahren zur Herstellung von Difluoracetophenon-Derivaten
DE69815906D1 (de) Verfahren zur Herstellung von Chloroacetylaminothiazoleaceticsäure Derivate
ATE206109T1 (de) Verfahren zur herstellung von carbamoylmethylharnstoff-derivaten
DE69834853D1 (de) 1H-pyrrolo i1,2-böi1,2,4ötriazolederivate, Zwischenprodukte und Verfahren zur Herstellung von 1H-1,2,4,-triazol-5-yl Essigsäureesterderivate
DE69916287D1 (de) Verfahren zur synthese von carbapenem-zwischenprodukten
DE3788369D1 (de) Verfahren zur Herstellung von Cephalosporinderivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI ASUBIO PHARMA CO., LTD., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: ASUBIO PHARMA CO., LTD., TOKYO, JP

8339 Ceased/non-payment of the annual fee